BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9 AND Diagnosis
4 results:

  • 1. Metabolic Discrimination of breast cancer Subtypes at the Single-Cell Level by Multiple Microextraction Coupled with Mass Spectrometry.
    Wang R; Zhao H; Zhang X; Zhao X; Song Z; Ouyang J
    Anal Chem; 2019 Mar; 91(5):3667-3674. PubMed ID: 30702862
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Patterns of cancer care costs in a country with detailed individual data.
    Blakely T; Atkinson J; Kvizhinadze G; Wilson N; Davies A; Clarke P
    Med Care; 2015 Apr; 53(4):302-9. PubMed ID: 25749656
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CKIT mutation in therapy-related acute myeloid leukemia with mllt3/MLL chimeric transcript from t(9;11)(p22;q23).
    Jung CL; Kim HJ; Kim DH; Huh H; Song MJ; Kim SH
    Ann Clin Lab Sci; 2011; 41(2):193-6. PubMed ID: 21844580
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.
    Chandra P; Luthra R; Zuo Z; Yao H; Ravandi F; Reddy N; Garcia-Manero G; Kantarjian H; Jones D
    Am J Clin Pathol; 2010 May; 133(5):686-93. PubMed ID: 20395514
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.